Why is Rossari Biotech falling/rising?

As of 12-Sep, Rossari Biotech Ltd is experiencing a decline in its stock price, currently at 628.00, which represents a decrease of 8.6 points or 1.35%. The stock has underperformed its sector by 2.23% today and has fallen after three consecutive days of gains. In terms of returns, the stock has shown a negative performance over various periods, with a year-to-date decline of 20.27% and a one-year drop of 29.52%. Additionally, the stock's delivery volume has decreased significantly, falling by 35.77% compared to the five-day average, indicating a reduction in investor participation. Despite a low debt-to-equity ratio and attractive valuation metrics, the stock's recent performance has been negatively impacted by falling profits and a lack of momentum.
In the broader market context, the Sensex has shown a positive return of 1.48% over the past week and 2.08% over the past month, contrasting sharply with Rossari Biotech's short-term decline. This underperformance against the benchmark suggests that investor sentiment may be shifting away from the stock, particularly given its substantial year-to-date and yearly losses. While high institutional holdings at 21.32% may provide some stability, the overall market conditions and the stock's inability to capitalize on recent gains have contributed to its current downward trajectory.